Related Experiment Video
Updated: Jul 15, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Directly observed highly active antiretroviral therapy for HIV-infected children in Cambodia
Patricia Myung1, David Pugatch, Mark F Brady
1Brown Medical School, Providence, RI, USA.
Insights
Directly observed antiretroviral therapy (ART) in Cambodia improved CD4 counts in HIV-infected children. This low-cost strategy, costing $5/child/month, ensures treatment adherence in resource-limited settings.
Area of Science:
- Global Health
- Pediatric Infectious Diseases
- Public Health
Background:
- Antiretroviral medications are increasingly accessible for children with HIV in resource-limited areas.
- Ensuring treatment adherence is a significant challenge in these settings.
Purpose of the Study:
- To evaluate the effectiveness and feasibility of directly observed antiretroviral therapy (DOART) for HIV-infected children in Phnom Penh, Cambodia.
- To assess treatment outcomes, adherence, and cost-effectiveness of DOART.
Main Methods:
- A cohort of 117 late-stage HIV-infected children received twice-daily generic antiretroviral drugs administered by child care workers.
- Treatment adherence was ensured through direct observation.
- Outcomes, including CD4 counts and drug toxicities, were monitored over at least six months.
Main Results:
- Despite an initial mortality of 22 children in the first six months, the remaining children showed CD4 count increases comparable to those in developed countries.
- Drug toxicities were infrequent and manageable.
- Program staffing costs were approximately US $5 per child per month, representing a 15% increase over medication costs.
Conclusions:
- Directly observed antiretroviral therapy is a viable and promising strategy for managing HIV in children within resource-limited environments.
- DOART effectively improves adherence and clinical outcomes, offering a cost-effective solution.
Abstract:
Antiretroviral medications are becoming available for HIV-infected children in resource-limited settings. Maryknoll, an international Catholic charity, provided directly observed antiretroviral therapy to HIV-infected children in Phnom Penh, Cambodia. Child care workers administered generic antiretroviral drugs twice daily to children, ensuring adherence. Treatment began with 117 late-stage HIV-infected children; 22 died of AIDS during the first 6 months. The rest were treated for at least 6 months and showed CD4 count increases comparable to those achieved in US and European children. Staffing cost for this program was approximately US $5 per child per month, or 15% more than the price of the medications. Drug toxicities were uncommon and easily managed. Directly observed antiretroviral therapy appears to be a promising, low-cost strategy for ensuring adherent treatment for HIV-infected children in a resource-limited setting.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Pharmacokinetics in Pediatric Patients: Drug Excretion

